Gram-negative endocarditis

Current Infectious Disease Reports

Volumn 10, Issue 4, 2008, Pages 267-274

  Reyes, Milagros P ^a   Reyes, Katherine C ^b  

^a HARPER UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIINFECTIVE AGENT; AZTREONAM; CARBAPENEM; CARBENICILLIN; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; COLISTIMETHATE; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; OFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULTAMICILLIN; TICARCILLIN; TIGECYCLINE; TIMENTIN; TOBRAMYCIN;

ACHROMOBACTER; ACINETOBACTER; ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANTIBIOTIC RESISTANCE; AORTA SURGERY; AORTA VALVE REGURGITATION; BACTEREMIA; BACTERIAL ENDOCARDITIS; CARDIOBACTERIUM HOMINIS; CATHETER INFECTION; COMBINATION CHEMOTHERAPY; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EIKENELLA CORRODENS; ENTEROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS APHROPHILUS; HAEMOPHILUS PARAINFLUENZAE; HAEMOPHILUS PARAPHROPHILUS; HEART VALVE REPLACEMENT; HOSPITAL INFECTION; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; KINGELLA; KLEBSIELLA PNEUMONIAE; MONOTHERAPY; MORTALITY; NONHUMAN; POSTOPERATIVE COMPLICATION; PROGNOSIS; PROSTHETIC VALVE ENDOCARDITIS; PSEUDOMONAS AERUGINOSA; RECOMMENDED DRUG DOSE; REVIEW; SALMONELLA; SALMONELLOSIS; SERRATIA MARCESCENS; SINGLE DRUG DOSE; STENOTROPHOMONAS MALTOPHILIA; TREATMENT DURATION; TRICUSPID VALVE; URINARY TRACT INFECTION; WATER CONTAMINATION;

EID: 56349084723     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-008-0044-5     Document Type: Review

References (47)

1. Pelletier LL Jr, Petersdorf RG: Infective endocarditis: a review of 125 cases from the University of Washington Hospitals, 1963-72. Medicine (Baltimore) 1977, 56:287-313.
2. Cohen PS, Maguire JH, Weinstein L: Infective endocarditis caused by gram-negative bacteria: a review of the literature, 1945-1977. Prog Cardiovasc Dis 1980, 22:205-242.
3. Geraci JE, Wilson WR: Symposium on infective endocarditis due to gram-negative bacteria. Report of 56 cases. Mayo Clin Proc 1982, 57:145-148.
4. Cabell CH, Barsic B, Bayer AS, et al.: Clinical findings, complications, and outcomes in a large prospective study of definite endocarditis: the International Collaboration on Endocarditis-Prospective Cohort Study [abstract 22]. Presented at the 7th International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections. Chamonix, France; June 26-28, 2003.
5. Snyder N, Atterbury CE, Pinto Correira J, Cohn HO: Increased concurrence of cirrhosis and bacterial endocarditis. A clinical and postmortem study. Gastroenterology 1977, 73:1107-1113.
6. Pendergrast BD: The changing face of infective endocarditis. Heart 2006, 92:879-885.
7. Schneider PJ, Nernoff J 3rd, Gold JA: Acute Salmonella endocarditis. Report of a case and review. Arch Intern Med 1967, 120:478-486.
8. Carruthers MM: Endocarditis due to enteric bacilli other than Salmonellae: case reports and literature review. Am J Med Sci 1977, 273:203-211.
9. Fernandez Guerrero ML, Aguado JM, Arribas A, et al.: The spectrum of cardiovascular infections due to Salmonella enterica. Medicine (Baltimore) 2004, 83:123-138.
10. Gould K, Ramirez-Ronda CH, Holmes RK, Sanford JP: Adherence of bacteria to heart valves in vitro. J Clin Invest 1975, 56:1364-1370.
11. Watanakunakorn C, Kim J: Mitral valve endocarditis caused by a serum-resistant strain of Escherichia coli. Clin Infect Dis 1992, 14:501-505.
12. Branger S, Casalta JP, Habib G, et al.: Escherichia coli endocarditis: seven new cases in adults and review of the literature. Eur J Clin Microbiol Infect Dis 2005, 24:537-541.
13. Joly V, Pangon B, Vallois JM, et al.: Value of antibiotic levels in serum and cardiac vegetations for predicting anti-bacterial effect of ceftriaxone in experimental Escherichia coli endocarditis. Antimicrob Agents Chemother 1987, 31:1632-1639.
14. Mills J, Drew D: Serratia marcescens endocarditis: a regional illness associated with intravenous drug abuse. Ann Intern Med 1976, 84:29-35.
15. Potel G, Caillon J, Le Gallou F, et al.: Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis. Antimicrob Agents Chemother 1996, 40:1164-1169.
16. Anderson MJ, Janoff EN: Klebsiella endocarditis: report of two cases and review. Clin Infect Dis 1998, 26:468-474.
17. Thomas MG, Rowland-Jones S: Klebsiella pneumoniae endocarditis. J R Soc Med 1989, 82:114-115.
18. Aubron C, Charpentier J, Trouillet JL, et al.: Native-valve infective endocarditis caused by Enterobacteriaceae: report on 9 cases and literature review. Scand J Infect Dis 2006, 38:873-881.
19. Tunkel AR, Fisch MJ, Schlein A, et al.: Enterobacter endocarditis. Scand J Infect Dis 1992, 24:233-240.
20. Das M, Badley AD, Cockerill FR, et al.: Infective endocarditis caused by HACEK microorganisms. Annu Rev Med 1997, 48:25-33.
21. Baron EJ, Scott JD, Tompkins LS: Prolonged incubation and extensive subculturing do not increase recovery of clinically significant microorganisms from standard automated blood culture bottles. Clin Infect Dis 2005, 41:1677-1680.
22. Weinstein MP: Emerging data indicating that extended incubation of blood cultures has little clinical value [editorial comment]. Clin Infect Dis 2005, 41:1681-1682.
23. Huang S, Lee H, Lee N, et al.: Clinical characteristics of invasive Haemophilus aphrophilus infections. J Microbiol Immunol Infect 2005, 38:271-276.
24. Paturel L, Casalta JP, Habib G, et al.: Actinobacillus actinomycetemcomitans endocarditis. Clin Microbiol Infect 2004, 10:98-118.
25. Malani AN, Aronoff DM, Bradley SF, Kauffman CA: Cardiobacterium hominis endocarditis: two cases and a review of the literature. Eur J Clin Microbiol Infect Dis 2006, 25:587-595.
26. Baddour LM, Wilson WR, Bayer AS, et al.: Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications. Circulation 2005, 111:394-434.
27. Reyes MP, Palutke, WA, Wylin RF, Lerner AM: Pseudomonas endocarditis in the Detroit Medical Center, 1969-1972. Medicine (Baltimore) 1973, 52:173-194.
28. Noriega ER, Rubenstein, E, Simberkoff MS, Rahal JJ: Sub-acute and acute endocarditis due to Pseudomonas cepacia in heroin addicts. Am J Med 1975, 59:29-36.
29. Rajashekaraiah KR, Rice TW, Kallick CA: Recovery of Pseudomonas aeruginosa from syringes of drug addicts with endocarditis. J Infect Dis 1981, 144:482.
30. Crane LR, Levine DP, Zervos MJ, Cummings G: Bacteremia in narcotic addicts at the Detroit Medical Center. I. Microbiology, epidemiology, risk factors, and empiric therapy. Rev Infect Dis 1986, 8:364-373.
31. Botsford KB, Weinstein RA, Nathan CR, Kabins SA: Selective survival in pentazocine and tripelennamine of Pseudomonas aeruginosa serotype 011 from drug addicts. J Infect Dis 1985, 151:209-216.
32. Reyes MP, Brown WJ, Lerner AM: Treatment of patients with pseudomonas endocarditis with high-dose aminoglycoside and carbenicillin therapy. Medicine (Baltimore) 1978, 57:57-67.
33. Reyes MP, Lerner AM: Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa. Rev Infect Dis 1983, 5:314-320.
34. Arbulu, MD, Asfaw I: Tricuspid valvulectomy without prosthetic replacement. Ten years of clinical experience. J Thorac Cardiovasc Surg 1981, 82:684-691.
35. Myerowitz PD, Gardner P, Campbell C, et al.: Earlier operation for left-sided pseudomonas endocarditis in drug addicts. J Thorac Cardiovasc Surg 1979, 77:577-581.
36. Wieland M, Lederman MM, Kline-King C, et al.: Left-sided endocarditis due to Pseudomonas aeruginosa. A report of 10 cases and review of the literature. Medicine (Baltimore) 1986, 65:180-189.
37. Komshian SV, Tablan OC, Palutke W, Reyes MP: Characteristics of left-sided endocarditis due to Pseudomonas aeruginosa in the Detroit Medical Center. Rev Infect Dis 1990, 12:693-702.
38. Ali A, DeMarco C, Reyes MP: Resurgence of Pseudomonas endocarditis (PsE) in Detroit, 2006. Presented at the XLV Annual Meeting of the Infectious Diseases Society of America. San Diego, CA; October 4-7, 2007.
39. Fichtenbaum CJ, Smith MJ: Treatment of endocarditis due to Pseudomonas aeruginosa. Clin Infect Dis 1992, 14:353-354.
40. King JH, Kailath EJ, Hrdy DB: Successful use of higher-than-recommended dosage of imipenem in Pseudomonas aeruginosa endocarditis. Ann Pharmacother 1992, 26:639-641.
41. Gavin PJ, Suseno MT, Cook FV, et al.: Left-sided endocarditis caused by Pseudomonas aeruginosa: successful treatment with meropenem and tobramycin. Diagn Microbiol Infect Dis 2003, 47:427-430.
42. Duran CM: Acquired disease of the tricuspid valve. In Sabiston and Spencer Surgery of the Chest. Edited by Selke FW, del Nido PJ, Swanson SJ. Philadelphia: Elsevier Saunders; 2005:1335-1354.
43. Shipton SE, Cotton MF, Wessels G, Wasserman E: Nosocomial endocarditis due to extended-spectrum beta-lactamase producing Klebsiella pneumoniae in a child. S Afr Med J 2001, 91:321-322.
44. Zimhony O, Chmelnitsky I, Bardenstein R, et al.: Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility. Antimicrob Agents Chemother 2006, 50:3179-3182.
45. Gradon JD, Chapnick EK, Lutwick LI: Infective endocarditis of a native valve due to Acinetobacter: case report and review. Clin Infect Dis 1992, 14:1145-1148.
46. Gomez-Cerezo J, Suarez I, Rios JJ, et al.: Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Eur J Clin Microbiol Infect Dis 2003, 22:360-363.
47. Khan IA, Mehta NJ: Stenotrophomonas maltophilia endocarditis: a systematic review. Angiology 2002, 53:49-55.